). </p>

<p>The IRB's SR/NSR determination has significant consequences for the study sponsor, FDA,
and prospective research subjects. SR device studies must be conducted in accordance with
the full IDE requirements [21 CFR part 812], and may not commence until 30 days following
the sponsor's submission of an IDE application to FDA. Submission of the IDE application
enables FDA to review information about the technical characteristics of the device, the
results of any prior studies (laboratory, anima